David G Lott

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi request reprint T-cell primary cutaneous anaplastic large cell lymphoma mimicking appearance of large basal cell carcinoma
    David G Lott
    Head and Neck Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Otolaryngol Head Neck Surg 135:170-1. 2006
  2. doi request reprint A new mouse laryngeal transplantation rejection grading system
    David G Lott
    Cleveland Clinic Head and Neck Institute, Cleveland, Ohio 44195, USA
    Laryngoscope 120:39-43. 2010
  3. doi request reprint Decoy NF-kappaB fortified immature dendritic cells maintain laryngeal allograft integrity and provide enhancement of regulatory T cells
    David G Lott
    Cleveland Clinic Head and Neck Institute, Cleveland, Ohio 44195, USA
    Laryngoscope 120:44-52. 2010
  4. doi request reprint Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients
    David G Lott
    Cleveland Clinic Head and Neck Institute, Cleveland, OH 44195, USA
    Transplantation 90:683-7. 2010
  5. doi request reprint Long-term laryngeal allograft survival using low-dose everolimus
    David G Lott
    Cleveland Clinic Head and Neck Institute, Cleveland, OH, USA
    Otolaryngol Head Neck Surg 142:72-8. 2010
  6. ncbi request reprint Ten-month laryngeal allograft survival with use of pulsed everolimus and anti-alphabeta T-cell receptor antibody immunosuppression
    David G Lott
    Cleveland Clinic Head and Neck Institute, Cleveland, Ohio, USA
    Ann Otol Rhinol Laryngol 120:131-6. 2011
  7. ncbi request reprint New mouse model for studying laryngeal transplantation
    Taha Z Shipchandler
    Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio, USA
    Ann Otol Rhinol Laryngol 118:465-8. 2009
  8. doi request reprint Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis
    David G Lott
    Cleveland Clinic, Cleveland, Ohio 44195, USA
    Laryngoscope 119:567-70. 2009
  9. ncbi request reprint Pathology quiz case 2. Diagnosis: dermatopathic lymphadenitis
    David G Lott
    Cleveland Clinic, OH, USA
    Arch Otolaryngol Head Neck Surg 133:729-31. 2007

Detail Information

Publications9

  1. ncbi request reprint T-cell primary cutaneous anaplastic large cell lymphoma mimicking appearance of large basal cell carcinoma
    David G Lott
    Head and Neck Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Otolaryngol Head Neck Surg 135:170-1. 2006
  2. doi request reprint A new mouse laryngeal transplantation rejection grading system
    David G Lott
    Cleveland Clinic Head and Neck Institute, Cleveland, Ohio 44195, USA
    Laryngoscope 120:39-43. 2010
    ..Prior to initiating immunosuppressive research protocols, a reliable mouse larynx rejection classification had to be established...
  3. doi request reprint Decoy NF-kappaB fortified immature dendritic cells maintain laryngeal allograft integrity and provide enhancement of regulatory T cells
    David G Lott
    Cleveland Clinic Head and Neck Institute, Cleveland, Ohio 44195, USA
    Laryngoscope 120:44-52. 2010
    ..The purpose of this study was to explore whether tolerogenic properties of iDC can be applied to composite tissue transplantation...
  4. doi request reprint Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients
    David G Lott
    Cleveland Clinic Head and Neck Institute, Cleveland, OH 44195, USA
    Transplantation 90:683-7. 2010
    ..The purpose of this study was to determine the aggressiveness of nonmelanotic skin cancers in a large transplant population compared with an immunocompetent control population with similar cancers...
  5. doi request reprint Long-term laryngeal allograft survival using low-dose everolimus
    David G Lott
    Cleveland Clinic Head and Neck Institute, Cleveland, OH, USA
    Otolaryngol Head Neck Surg 142:72-8. 2010
    ..The purpose of this study was to explore the mechanism and utility of everolimus as a single-agent therapy in preventing mouse laryngeal allograft rejection...
  6. ncbi request reprint Ten-month laryngeal allograft survival with use of pulsed everolimus and anti-alphabeta T-cell receptor antibody immunosuppression
    David G Lott
    Cleveland Clinic Head and Neck Institute, Cleveland, Ohio, USA
    Ann Otol Rhinol Laryngol 120:131-6. 2011
    ..Pulsed immunosuppressive dosing can lessen these risks. The study objective was to develop a long-term pulsing regimen that minimizes exposure to immunosuppressive agents...
  7. ncbi request reprint New mouse model for studying laryngeal transplantation
    Taha Z Shipchandler
    Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio, USA
    Ann Otol Rhinol Laryngol 118:465-8. 2009
    ..The purpose of this study was to develop a reliable surgical technique in mice to serve as a model for further study of laryngeal transplantation...
  8. doi request reprint Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis
    David G Lott
    Cleveland Clinic, Cleveland, Ohio 44195, USA
    Laryngoscope 119:567-70. 2009
    ..Although causation is not shown, we believe the association presented is a valuable addition to the literature and an important consideration in the use of cidofovir...
  9. ncbi request reprint Pathology quiz case 2. Diagnosis: dermatopathic lymphadenitis
    David G Lott
    Cleveland Clinic, OH, USA
    Arch Otolaryngol Head Neck Surg 133:729-31. 2007